UK vaccine clinical trial outsourcing expansion continues
An outsourcing company has announced that Phase II, III and…
An outsourcing company has announced that Phase II, III and IV clinical trials of vaccines will continue at a growing number of sites, assessing the safety of each in light of COVID-19.